Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/4/24 16:41 | 12/11/23 | FLGT | Health | Health | Medical Laboratories | Xie Jian | CA | O | P,COO | 7 | S | -769 | 25.76 | 0 | -30 | 608 | D | |||||||||||||||
12/4/24 16:40 | 12/4/23 | FLGT | Health | Health | Medical Laboratories | Gao Hanlin | CA | O | Chief Sc | 5 | S | -121 | 22.58 | 0 | -5 | 925 | D | |||||||||||||||
11/27/24 17:00 | 11/25/24 | FLGT | Health | Health | Medical Laboratories | Hsieh Ming | CA | DOT | CEO | 2 | S | -93 | 20.59 | 0 | -5 | 0 | 8,825 | D | ||||||||||||||
9/5/24 16:21 | 12/4/23 | FLGT | Health | Health | Medical Laboratories | Kim Paul | CA | O | CFO,Trea | 4 | S | -129 | 24.99 | 0 | -5 | 211 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |